AveXis Presents Initial Data from Pivotal U.S. Trial for SMA Type 1 and 24-Month Follow-Up Data from Phase 1 Trial of AVXS-101 in SMA Type 1 at the Annual Meeting of the American Academy of Neurology

Bud Bilanich
Success Coach

Frank Burrell
Scientific Storytelling

Matt Turner
Patient Affordability

Matthew Durham
Omnidynamic Marketing

Joey Cohen
Medication Adherence

Brenda Snow
Authentic Patient Voice

Paul Theisen
Patient Acquisition

Suma Ramadas, PhD
Medical Affairs

Amy Giles
Increasing Engagement

Liz Kane
Impactful Strategy

Daniel Sontupe
Market Access

Pat Purcell
Meeting Engagement

David Linetsky
Point-of-Care Marketing

Stacey Gandler
Brand Nourishment